AI
Discover the World’s Fastest Business Insights
Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.
Icon O Vir Bio announced it raised $20.2 Million in an initial filing from an offering of $20.2 Million
Icon O Vir Bio announced it raised $20.2 Million in an initial filing from an offering of $20.2 Million
06/21/23, 2:29 PM
Location
san diego
Money raised
$20.2 million
Industry
biotechnology
Company Info
Location
4570 executive drive
san diego, california, united states
Additional Info
IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer. Our proprietary oncolytic virus platform is based on technology developed by scientific founder Clodagh O’Shea, Ph.D., of the Salk Institute. It is designed to address key limitations of first- and second-generation oncolytic viruses.
Never Miss an Opportunity: Your #1 Sales Intelligence Tool
Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.
Related people
JH
JH
MH
SH